The gut microbiome comprises the community of microorganisms in the intestinal tract. Research suggests that an altered microbiome may play a role in a wide range of disorders including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Methods: 42 participants with ME/CFS with Irritable Bowel Syndrome (IBS) were allocated into one of two groups, 21 were treated with standard oral approaches, which centred around various nutritional remedies, probiotics, prebiotics, dietary advice and lifestyle advice. The second group who had mostly failed using oral approaches, were treated with Faecal Microbiome Transplantation (FMT). Each patient received 10 Implants, each from a different screened donor, and the Implants were processed under anaerobic conditions. The transplant is delivered via a paediatric rectal catheter, which is inserted through the anus to reach the lower part of the sigmoid colon.
Introduction
The gut microbiome comprises the community of microorganisms in the intestinal tract. Over the last five years, interest in the gut microbiome has grown considerably driven by new techniques in DNA sequencing allowing for characterisation of gut bacteria and the recognition of the potential impact the microbiome may have on health [1, 2] . The large intestine has the highest number of microbial organisms, with less found in the more hostile low-pH environment of the small intestine. The large intestine is dominated by anaerobic bacteria which survive and thrive by anaerobically digesting our food [3] [4] [5] . The gut microbiome has coevolved with humans to match our modern lifestyles [6] and is beneficial for our health, supplying essential nutrients, synthetizing vitamins (i.e. vitamin K) and facilitating digestion of undigested carbohydrates [7] [8] [9] . Furthermore, bacteria also help maintain the integrity of the mucosal barrier by preventing antigens and pathogens entering the gut mucosa [10, 11] .
In healthy adults, 80% of the identified faecal microbiota can be classified into three dominant phyla: Bacteroides, Firmicutes and Actinobacteria. In general terms, the Firmicutes to Bacteroides ratio is regarded to be of significant relevance in the human gut microbiota composition. High Firmicutes and low Bacteroides usually correlates with a healthy diverse microbiome and reflects a largely plant-based diet. In unhealthy microbiomes the opposite is the case and may well be due to a more western type diet [12, 13] . Alterations in the composition of the microbiome has the potential to significantly impact on our health and wellbeing. One of the side effects of antibiotic use is a change in gut microflora that allows overgrowth of harmful micro-organisms [14] . Clostridium Difficile-associated diarrhoea for example is a well-recognised infection linked to previous antibiotic use [15] . Furthermore, studies on young children with a developing microbiome have shown that antibiotics are especially likely to cause long lasting https://doi.org/10.1016/j.humic.2019.100061 ⁎ Corresponding author. T adverse changes [16] [17] [18] . Regulation of the gut flora has also been correlated with a host of inflammatory and immune conditions [19, 20] . Recent changes in lifestyle including reduced exposure to pathogens in early life, dietary changes to a high intake of carbohydrates and fats from processed foods and reduced dietary fibre have been proposed to play a role in the rise of inflammatory conditions such as inflammatory bowel disease (IBS/D) and Crohn's disease [19, 20] . The microbiome has been shown to have profound effects in the development of gutassociated lymphoid tissue, differentiation of gut immune cells and production of immune mediators such as IgA's and microbial defence peptides [21] . Recent research suggests that an altered microbiome may play a role in a wide range of disorders including Parkinson's disease [22, 23] chronic liver disease [24, 25] , myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) [26, 27] and also impact cancer patient recovery after treatments such as chemotherapy and radiotherapy [28] .
In this study we randomly chose 21 patients from our sizeable population of Chronic Fatigue Syndrome patients. These patients were treated using oral approaches and also lifestyle and dietary advice. Then, 21 patients with Chronic Fatigue Syndrome who were treated with Faecal Microbiome Transplantation (FMT).
Materials and methods
All our Chronic Fatigue Syndrome patients were assessed using the agreed international consensus criteria for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis [29] .
Other possible diagnoses in all of these patients were ruled out with appropriate clinical examination and appropriate investigations by their General Practitioners prior to seeing us.
We divided the patients into two groups of 21 per group. 21 were treated with standard oral approaches, which centred around various nutritional remedies, probiotics, prebiotics, dietary advice and lifestyle advice. The second group were treated with FMT and the second group had mostly failed using oral approaches.
In the Faecal Microbiome Transplantation population in this study, each patient was implanted with 10 Implants, each from a different screened donor and we have found in clinical practice that 10 Implants is an optimal number, the Implants are processed under anaerobic conditions. The criteria for Chronic Fatigue Syndrome is as per Carruthers BM, van de Sande MI, et al. [29] .
Donors are screened and undergo testing for many common communicable diseases to ensure that the procedure is done as safely as possible, but it is not possible to test donors for all possible organisms and some infections may be undetectable. To date there have not been any documented cases of an infection transmitted through FMT. The donor verifies that he/she has no history of: We used Implants supplied by The Taymount Laboratory https:// taymount.com/.
The results were assessed on a percentage basis before and after treatment, 0% being no improvement, 100% being maximum improvement. In no case did we obtain more than a 95% response. This is a clinical judgement as there is no objective test for Chronic Fatigue Syndrome.
Essentially, FMT represents the transfer of the faecal microbiota from healthy donors to diseased recipients in order to restore a balanced gut microbial ecology, and in turn foster resolution of symptoms.
A liquid suspension of homogenised stool is instilled into the sigmoid colon using a paediatric catheter [ Table 2 ]. Every patient in this study signed an Informed Consent allowing anonymous use of their data.
One patient reacted to several of the implants with diarrhoea, so we had to stop the implants. One other patient only managed to tolerate half of the implants. Other than that, there were no other adverse effects from the treatment.
Analysis
The data were tested for normality and an exact non-parametric Mann-Whitney (one-tailed) test was used to compare medians from those on FMT compared with those receiving oral approaches only.
Results
The results are attached in Tables 1 and 2 . The median for the FMT group was found to be significantly higher compared to the oral treatment group (Mann-Whitney U = 111.5, p = .003). Therefore, the FMT group improved to a greater extent (z = −2.761).
Discussion
Chronic Fatigue Syndrome is relatively common [30] . Chronic Fatigue Syndrome is often a co-morbid clinical condition with Irritable Bowel Syndrome [31, 32] .
We know that in the microbiome of Chronic Fatigue Syndrome patients the intestinal microbiome is abnormal [33, 34] . Essentially, FMT represents the transfer of the faecal microbiota from healthy donors to diseased recipients in order to restore a balanced gut microbial ecology, and in turn foster resolution of symptoms [35] . FMT has been used for many years for the treatment of Clostridium Difficile (CDiff) and more recently for conditions such as Irritable Bowel Syndrome and Ulcerative Colitis with significant studies published to support these uses [36] .
The notion of the faecal transplant as a therapeutic invention is not new, as this procedure was first performed almost two millennia ago by a Chinese Medical Scientist named Ge Hong [37] .
Compared to Probiotics, which act temporarily, the satisfactory outcome of treatment with FMT suggests that faeces contain a superior combination of intestinal bacterial strains and is more favourable for repairing disrupted native microbiota by introducing a complete, stable community of intestinal micro-organisms [38] . Likewise, faeces contain other factors, proteins, vitamins and bile acids, which may enhance gut recovery [39] .
A recent very interesting study shows that in patients with Irritable Bowel and Chronic Fatigue Syndrome, there is an authentic blood microbiome in non-communicable diseases. The chief origin of these microbes is the gut microbiome (especially when it shifts composition to a pathogenic state known as (Dysbiosis').
This study has significant limitations as it is a retrospective Observational Outcomes Study, it is not a Randomised Control Trial. The aim is to encourage proper Randomised Control Studies to be carried out in this area, because our Observational Outcomes Study here showed benefits amongst many patients, so this area is worth investigating further.
From our current study and from the effectiveness of Faecal Microbiome Transplantation, it would appear that this hypothesis is the first event that can result in Chronic Fatigue Syndrome associated with Irritable Bowel Syndrome [40] .
Conclusion
Faecal Microbiome Transplantation is a safe, and from this study, an encouraging treatment for Chronic Fatigue Syndrome associated with Irritable Bowel Syndrome. This study argues for carrying out a Randomised Controlled Study of Chronic Fatigue Syndrome and Irritable Bowel Syndrome patients. 
75%
(F) Age 56 History of Chronic Fatigue Syndrome, Irritable Bowel Syndrome for many years. Resistant to oral approaches for treating both of these conditions. We carried out FMT in May 2018. Since that time her energy is significantly better, and remains better, bowel function is now normal.
80%
(F) Age 70 Chronic Fatigue Syndrome for many years, also Irritable Bowel Syndrome. We treated her with FMT in October 2017. Bowel habit is now normal, resistance to intercurrent infections has now returned to normal, energy was consistently improved and remains so.
95%
(M) Age 65 Chronic Fatigue Syndrome for many years. We treated him with FMT in November 2017. Energy has returned to normal. 95% (F) Age 52
This patient has had Chronic Fatigue Syndrome for many years. Also, Irritable Bowel Syndrome. We treated her with FMT in July 2018. Since then, her energy has returned to normal and she has now been able to return to work, her gut has also returned to normal.
(F) Age 48 History of Chronic Fatigue Syndrome and Irritable Bowel for many years. We carried out FMT on her in March 2018. Since then her Irritable Bowel Syndrome has cleared up completely and also her energy has returned to normal. 
